biotech · Chronic Hepatitis B · Chronic Hepatitis B Infection · ALGS
Aligos Therapeutics
Aligos Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
1 Corporate Dr, South San Francisco, California 94080, US HQ
2018 Founded
98 Employees
Public company Type
ALGS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1 Corporate Dr, South San Francisco, California 94080, US
- Founded
- 2018
- Employees
- 98
- Programs
- 14
- Drugs
- 10
- Patents
- 32
Aligos Therapeutics clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to Aligos Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Aligos Therapeutics trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Aligos Therapeutics.
-
ALG-000184-202 — Phase 2
Clinical update -
Atorvastatin — Phase 1
Clinical update -
ALG-097558 — Phase 1
Clinical update -
ALG-055009 — Phase 1
Clinical update -
ALG-000184 — Phase 2
Clinical update -
ALG-055009 — Phase 2
Clinical update -
ALG-000184 — Phase 1
Clinical update -
ALG-010133 — Phase 1
Clinical update